Table 1

The 6-gene signature selected by BMA that discriminates chronic phase from blast crisis CML

IDGeneChromosome locationActivityCellular functionPosterior probabilities, %Univariate (BSS/WSS) rank
NM_016355 DDX47 12p13.1 RNA helicase RNA processing, apoptosis 20.5 
NM_004258 IGSF2 1p13 Signal transduction Immune function, T-cell activation 20.5 
NM_000752 LTB4R 14q11.2-q12 5-lipoxy-genase Cell growth, apoptosis 20.5 
NM_014062 NOB1 16q22.1 Unknown Unknown 20.5 13 
NM_005505 SCARB1 12q24.31 Cholesterol scavenger receptor HDL and LDL metabolism 20.5 69 
NM_005888 SLC25A3 12q23 Mitochondrial phosphate transport ATP synthesis 20.5 77 
IDGeneChromosome locationActivityCellular functionPosterior probabilities, %Univariate (BSS/WSS) rank
NM_016355 DDX47 12p13.1 RNA helicase RNA processing, apoptosis 20.5 
NM_004258 IGSF2 1p13 Signal transduction Immune function, T-cell activation 20.5 
NM_000752 LTB4R 14q11.2-q12 5-lipoxy-genase Cell growth, apoptosis 20.5 
NM_014062 NOB1 16q22.1 Unknown Unknown 20.5 13 
NM_005505 SCARB1 12q24.31 Cholesterol scavenger receptor HDL and LDL metabolism 20.5 69 
NM_005888 SLC25A3 12q23 Mitochondrial phosphate transport ATP synthesis 20.5 77 

The table indicates chromosomal location, function, the posterior probability of each gene in multivariate modeling, and its rank in univariate modeling (using the univariate measure of the ratio of between-group to within-group sum of squares (BSS/WSS).

BMA indicates Bayesain modeling averaging; and CML, chronic myeloid leukemia.

or Create an Account

Close Modal
Close Modal